Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 451-460 of 2904 for cancer

Edit search filters
  1. Radiation Therapy With Or Without Apalutamide In Treating Patients With Stage III-IV Prostate Cancer

    Albert Lea, MN

  2. Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer

    Mankato, MN

  3. A Study To Evaluate Chemoradiotherapy With Or Without Atezolizumab In Treating Patients With Localized Muscle Invasive Bladder Cancer

    Scottsdale/Phoenix, AZ, Eau Claire, WI, La Crosse, WI, Rochester, MN

  4. Phase 1 Trial Of ST-001 NanoFenretinide In Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

    Scottsdale/Phoenix, AZ

  5. A Global Phase III Study Of Rilvegostomig Or Pembrolizumab Plus Chemotherapy For First-Line Treatment Of Metastatic Non-squamous NSCLC

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. Dose-Escalation Study Of Cevostamab (BFCR4350A) In Participants With Relapsed Or Refractory Multiple Myeloma (R/R MM)

    Scottsdale/Phoenix, AZ

  7. A Study Of Tucatinib Or Placebo With Trastuzumab And Pertuzumab For Metastatic HER2+ Breast Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. Study Of AZD5863 In Adult Participants With Advanced Or Metastatic Solid Tumors

    Jacksonville, FL, Rochester, MN

  9. Optical Fusion Trans-Perineal Grid

    Rochester, MN

  10. A Study of Paclitaxel with or without Cixutumumab as Second-Line Therapy for Treating Patients with Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer